Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | EX434 | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | 2117047 | — |
No additional AE; administered 1 dose of ROTARIX and 1 dose of ROTATEQ due to a documentation error; This spontaneous report was from a nurse and refers to a 4-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-Jun-2025, the patient was vaccinated with the first dose of rotavirus vaccine live oral 1v (ROTARIX) (lot # EX434, expiration date: 01-Jun-2026) as prophylaxis. After administering dose, the nurse inadvertently documented the dose in their system as Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq). On 03-Sep-2025, the patient was vaccinated with Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), (valid lot #2117047, expiration date: 18-May-2026), 2 mL, as prophylaxis due to a documentation error in accordance with the previously documented dose, which was documented incorrectly. (wrong vaccine administered). No were symptoms reported. No additional adverse event (AE) was reported.